Shares of Merck & Co. Inc. MRK slid 1.72% to $96.24 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.88% to 6,049.24 and ...
Verizon is a telecommunications powerhouse renowned for its consistent dividend payments. As of January 21, 2025, its stock ...
Eight of the 30 Dow components lost value in 2024. Here's a quick look at each company, to help you determine which dividend ...
NAMSA recently announced plans to acquire WuXi AppTec’s medical device testing operations in the U.S. As part of the ...
Shares of Summit Therapeutics ( SMMT 15.40%) had jumped 14.3% at 11:31 a.m. ET on Tuesday. The nice gain came after reports ...
Leo Pharma has stepped up to commercialize toripalimab in Europe, inking a deal with Shanghai Junshi Biosciences to secure ...
We recently compiled a list of the 12 Stocks Under $5 With Biggest Upside Potential. In this article, we are going to take a ...
Morgan Stanley analyst Terence Flynn lowered the firm’s price target on Merck (MRK) to $113 from $123 and keeps an Equal Weight rating on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback